Barbosa, TM, Levy, SB. (2000) The impact of antibiotic use on resistance development and persistence. Drug Resistance Updates 3: 303–311.
Cafazzo, JA, St-Cyr, O. (2012) From discovery to design: the evolution of human factors in healthcare. Healthcare Quarterly 15: 24–29.
Duerdin, B, Fry, C, Johnson, A, Wilcox, M. (2015) The control of methicillin resistant Staphylococcus aureus blood stream infections in England. Open Forum Infectious Diseases 2: ofv035.
Global & Public Health Group . (2019) Contained and controlled: the UK’s 20-year vision for antimicrobial resistance. London: HM Government. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/773065/uk-20-year-vision-for-antimicrobial-resistance.pdf.
Global & Public Health Group . (2019) Tackling antimicrobial resistance 2019–2024: The UK’s five-year national action plan. London: HM Government. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/773130/uk-amr-5-year-national-action-plan.pdf.
World Health Organization. (2018) Improving infection prevention and control at the health facility: Interim practical manual supporting implementation of the WHO Guidelines on Core Components of Infection Prevention and Control Programmes. Geneva: WHO. Available at: https://www.who.int/infection-prevention/tools/core-components/facility-manual.pdf.
Wilson, J . (2018) Applying Pareto analysis to reducing Escherichia coli bloodstream infections. Journal of Infection Prevention 19: 208–210.
Lists
Lists
ORCID: https://orcid.org/0000-0002-4713-9662
(2019)
A strategy for tackling antimicrobial resistance: it’s more than a prescribing problem.
Journal of Infection Prevention, 20 (2).
pp. 64-65.
ISSN 1757-1774
